KMT2D Histone Methyltransferase Modulates Chromatin Accessibility During Regulatory T Cell Development (LYM6P.714)

Katarzyna Placek,Kairong Cui,Gangqing Hu,Ji-Eun Lee,Chaochen Wang,Joanne Konkel,Dunfang Zhang,WanJun Chen,Kai Ge,Keji Zhao
DOI: https://doi.org/10.4049/jimmunol.194.supp.135.2
2015-01-01
The Journal of Immunology
Abstract:Abstract Gene regulatory elements are associated with histone H3 lysine 4 (H3K4) methylation and H3 acetylation and DNase I hypersensitivity. Whilst much is known about changes in histone modification patterns and chromatin accessibility during T cell differentiation, little is known about the role of histone modifying enzymes in this process. KMT2D is a histone methyltransferase that shapes enhancer landscape by regulating H3K4me and H3K27ac. To determine whether KMT2D plays a role in T cell development, we deleted KMT2D in T cells. Our data show that KMT2D deficiency results in reduced number of T cells in periphery. Moreover in the absence of KMT2D, differentiation of regulatory T (Treg) cells is compromised. KMT2D co-localizes with active chromatin marks. We showed that DNaseI hypersensitive sites (HS) bound by KMT2D tend to decrease in accessibility upon KMT2D deletion in CD4+ T cells that leads to reduced expression of nearby genes. The decreased HS are linked to genes involved in Treg differentiation and are enriched in transcription factor (TF) binding motif important for CD4+ T cell development. We found that KMT2D co-localizes and interacts with TF in CD4+ T cells. KMT2D binds to Treg master regulator: Foxp3 upstream enhancer and imposes H3K4me1 and H3K4me2 at Foxp3 regulatory elements. Our data suggest that KMT2D modulates CD4+ T cell development by maintaining chromatin accessibility and thus enabling TFs binding at genes involved in Treg cell differentiation.
What problem does this paper attempt to address?